In TriNetX records, adults with obesity and CRP of 3 to 10 mg/L taking a GLP-1 drug were matched with metformin, orlistat or phentermine users. Over up to ten years, death, heart attack and stroke combined were lower in the 50,009 GLP-1 users (HR 0.80). Fewer deaths accounted for most of that (HR 0.61); heart attacks did not differ, while stroke and arrhythmias were modestly lower.
Why it is interesting: Almost all of the lower composite is fewer deaths, with heart attacks unchanged.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.